Immunologic and Virologic Parameters During Analytical Treatment Interruption Following Combination bNAb Therapy During Suppressive ART

NCT06908083 · clinicaltrials.gov ↗
PHASE1
Phase
ENROLLING_BY_INVITATION
Status
50
Enrollment
NIH
Sponsor class

Conditions

Interventions

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)